503639 — Apollo Ingredients Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Apollo Ingredients, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS |
Standards: | IAS | IAS | — |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0 | 10 | 30.7 |
Cost of Revenue | |||
Gross Profit | — | 2.6 | 7.01 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 1.06 | 9.21 | 29.5 |
Operating Profit | -1.06 | 0.793 | 1.25 |
Other Net Non Operating Costs | |||
Net Income Before Taxes | -0.732 | 0.823 | 1.32 |
Provision for Income Taxes | |||
Net Income After Taxes | -0.732 | 0.609 | 0.975 |
Net Income Before Extraordinary Items | |||
Net Income | -0.732 | 0.609 | 0.975 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -0.732 | 0.609 | 0.975 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -1.83 | 1.52 | 2.44 |